PHAT
PHAT
NASDAQ · Pharmaceuticals

Phathom Pharmaceuticals Inc

$8.98
+0.23 (+2.63%)
As of Aug 8, 1:44 AM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target +465.0% upside
Low Target $34.41
Average Target $50.74
High Target $70.04
Current Price $8.98
Current
$8.98
Target
$50.74
$34.41 $50.74 avg $70.04
Scenario Analysis
Bear Case
$34.41
283.2%
Low target
Base Case
$50.74
+465.0%
Avg target
Bull Case
$70.04
+680.0%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$18.31
-51.0% from high
52-Week Low
$8.03
+11.9% from low
Target vs 52W High
$50.74
+177.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%